In the case of Luminal A lobular carcinoma (initially classified as cTXN1), NAC was indicated due to a contralateral HER2-positive carcinoma (T3N0), and, surprisingly, the lobular carcinoma also regressed after NAC. The gene discussed is ERBB2; the disease is carcinoma.